Archives
-
Thymoquinone Workflows for Cardiotoxicity Research
2026-09-13
Build mechanism-resolved doxorubicin cardiotoxicity assays with Thymoquinone, from solvent handling through ferroptosis, oxidative-stress, and cardiac-function readouts. The workflow separates study-matched mouse dosing from practical cell-culture optimization while highlighting controls that distinguish antioxidant protection from nonspecific cytotoxicity.
-
5-Aminolevulinic Acid HCl in Heme Research
2026-09-12
5-Aminolevulinic acid HCl is more than an intermediate in heme biosynthesis: it is a useful probe for separating metabolic flux, bacterial immune evasion, and assay readouts. This article translates recent Salmonella findings into practical experimental decisions while defining the reagent’s relevance to cancer research.
-
Dynasore: From Endocytosis Tool to Translation Strategy
2026-09-11
Dynasore is more than a pathway inhibitor: it is a reversible perturbation tool for testing whether dynamin-dependent membrane fission drives uptake, trafficking, infection, neuronal recycling, or disease-relevant signaling. This article translates mechanistic evidence into practical experimental and translational strategy.
-
Cy5-UTP for Structure-Resolved RNA Probes
2026-09-11
Cy5-UTP enables bright, direct RNA detection while exposing an often-overlooked experimental variable: fluorescent labeling can influence RNA structure and RNA–protein binding. This guide translates XIST–SPEN research into a rigorous workflow for in vitro transcription RNA labeling, FISH, and multiplex assay design.
-
Beyond Viability: Resazurin in Sclerosteosis Research
2026-09-10
A translational framework for using resazurin-based viability measurements to strengthen PORCN inhibition studies in SOST-deficient high-bone-mass disease.
-
CX-5461 Triggers Mitotic Catastrophe in Cervical Cancer
2026-09-10
A June 2026 study reports that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage to aberrant mitotic entry and mitotic catastrophe. The work also provides a mechanistic rationale for combining Pol I inhibition with cisplatin, particularly in models relevant to treatment resistance.
-
Bradykinin B2 Receptors and Ileal Peristalsis
2026-09-09
Chan and Rudd showed that bradykinin inhibits the peristaltic reflex in guinea pig ileum through pharmacologically identifiable B2 receptors, rather than B1 receptors. Their agonist–antagonist design links receptor subtype selectivity to a functional motility endpoint and provides a useful framework for interpreting peptide signaling in gastrointestinal research.
-
Atorvastatin Workflows for Cholesterol and Ferroptosis
2026-09-09
Atorvastatin connects cholesterol biosynthesis, vascular signaling, and emerging ferroptosis assays in one experimentally tractable workflow. This guide translates its established cardiovascular research uses into practical HCC model design, dosing, controls, and troubleshooting strategies.
-
EZ Cap™ Cre mRNA: Assay Design Beyond Delivery
2026-09-08
Discover how EZ Cap™ Cre mRNA (m1Ψ) supports transient, loxP-directed recombination in gene editing and functional assays. This guide connects Cre assay design with emerging extrahepatic mRNA delivery while separating cargo performance from delivery-platform effects.
-
N1-Methylpseudouridine and Translation Fidelity
2026-09-08
The reference study directly tested whether N1-methylpseudouridine compromises ribosomal decoding, rather than inferring fidelity from translation yield alone. Its combined biochemical, cellular, RNA-structure, and reverse-transcription analyses indicate that the modification supports accurate protein synthesis while behaving differently from pseudouridine in mismatch stabilization.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-07
The reference study shows that CDC42-dependent apical-basal polarity regulates the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ-Ereg-mTOR cascade rather than through canonical Wnt signaling alone. Its conditional genetic and pharmacological experiments connect epithelial architecture with crypt proliferation and provide a framework for dissecting intestinal homeostasis.
-
Fulvestrant (ICI 182,780): ER Antagonist Guide
2026-09-07
Fulvestrant, also called ICI 182,780, is a selective estrogen receptor antagonist that promotes ERα downregulation and receptor degradation. Product data and peer-reviewed evidence support its use in ER-signaling studies, MDM2 protein degradation research, chemotherapy-sensitization assays, and endocrine therapy resistance research.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Guide
2026-09-05
Learn how N1-Methyl-Pseudouridine-5'-Triphosphate can improve RNA synthesis workflows, translation testing, and template-RNA stability. The guide also shows how to use controlled nucleotide substitution, junction assays, and repair-pathway logic when adapting RNA experiments to PRINT and retrotransposon insertion research.
-
UTP Solution (100 mM) in RNA Assay Design
2026-09-04
UTP Solution (100 mM) connects controlled nucleotide chemistry with high-confidence RNA measurements. This article interprets the TRIM66 olfactory-receptor study through an assay-design lens while defining practical uses, controls, and limitations for transcription-focused workflows.
-
Busulfan and Lineage Tracing: Reading Injury Correctly
2026-09-04
Busulfan is a DNA alkylating agent whose tissue injury, oxidative stress, and germ-cell effects can complicate interpretation of regeneration assays. This article explains how to pair Busulfan models with dual-recombinase lineage tracing to distinguish cellular depletion from genuine postnatal neo-oogenesis.